EC adds Cellnovo to R&D project to add artificial intelligence in Type 1 diabetes management

Connected insulin patch pump–Courtesy of Cellnovo Cellnovo Group ($CLNV) is already part of a major NIH trial for an artificial pancreas that incorporates its connected insulin pump-blood glucose monitor. Now, it’s joining a European Commission-sponsored R&D project to develop new technology aimed at Type 1 diabetics. Dubbed PEPPER (Patient Empowerment through Predictive Personalised decision support), the project is also being conducted with U.K. and European universities for better self-management of the disease. The three-year project is financed with almost €4 million ($4.5 million). “The Cellnovo diabetes management system is an ideal platform for a personalised decision support system because of its real-time connected data, as well as its wearability and discreetness,” said Cellnovo CEO Sophie Baratte in a statement. “The funding by the European Commission’s Horizon 2020 programme further demonstrates…


Link to Full Article: EC adds Cellnovo to R&D project to add artificial intelligence in Type 1 diabetes management

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!